improvement in serum biochemical alterations and oxidative stress of liver and pancreas following use of royal jelly in streptozotocin-induced diabetic rats

objective: this study aimed to evaluate the effects of royal jelly (rj) on serum biochemical alterations and oxidative stress status in liver and pancreas of streptozotocin (stz)- induced diabetic rats. materials and methods: in this experimental study, thirty two male wistar rats were divided into the following four groups (n=8/group): i. control (c), ii. diabetic (d), iii. royal jelly (r), and iv. royal jelly-treated diabetic (d/r) groups. diabetes was induced by single intraperitoneal (ip) injection of stz (60 mg/kg). the rj [100 mg/kg body weight (bw)] was administered orally for 42 days. blood samples were used to determine serum levels of insulin, high density lipoprotein cholesterol (hdl-c), total protein (tp), albumin, alanine aminotransferase (alt), aspartate aminotransferase (ast), alkaline phosphatase (alp), and fasting blood glucose (fbg). also, the antioxidant status was evaluated by determining the levels of malondialdehyde (mda), catalase (cat) and ferric reducing antioxidant power (frap) in liver and pancreas. data were analyzed by one-way analysis of variance (anova) with p<0.05 as the significant level. results: stz-induced diabetic rats showed a significant elevation in the serum levels of ast, alt, alp and fbg, whereas there was a significant decrease in serum levels of insulin, albumin, hdl-c and tp (p<0.05). treatment of the diabetic rats with rj restored the changes of the above parameters to their normal levels (p<0.05). in addition, rj significantly improved reduced levels of frap and cat as well as high mda level in liver and pancreas (p<0.05). conclusion: rj improves oxidative damage induced by stz in the liver and pancreas of rats; therefore, it can be considered as an effective and alternative treatment for diabetes.